Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cantor Fitzgerald
Healthtrust
Deloitte
Baxter
Express Scripts
McKesson
Colorcon
Cipla

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040411

« Back to Dashboard

NDA 040411 describes METHIMAZOLE, which is a drug marketed by Casi Pharms Inc, Eci Pharms Llc, Heritage Pharma, Mylan, Rising Pharms Inc, and Sun Pharm Inds Inc, and is included in seven NDAs. It is available from eighteen suppliers. Additional details are available on the METHIMAZOLE profile page.

The generic ingredient in METHIMAZOLE is methimazole. There are three drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the methimazole profile page.
Summary for 040411
Tradename:METHIMAZOLE
Applicant:Casi Pharms Inc
Ingredient:methimazole
Patents:0
Therapeutic Class:Hormonal Agents, Suppressant (Thyroid)
Formulation / Manufacturing:see details
Pharmacology for NDA: 040411
Medical Subject Heading (MeSH) Categories for 040411
Suppliers and Packaging for NDA: 040411
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHIMAZOLE methimazole TABLET;ORAL 040411 ANDA Eon Labs, Inc. 0185-0205 N 0185-0205-01
METHIMAZOLE methimazole TABLET;ORAL 040411 ANDA Eon Labs, Inc. 0185-0205 N 0185-0205-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Mar 27, 2001TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Mar 27, 2001TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Daiichi Sankyo
UBS
Cipla
US Army
Cerilliant
Dow
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.